HUSHAM A. ALDAOSERI; NAAEL HUSSEIN ALI; FIRES AL-MUBARAK. The effect of biological anti-TNF-α therapy, originator and biosimilar, used to treat ankylosing spondylitis was studied based on clinical and blood counts and an inflammatory marker. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 30, n. 5, p. 615–620, 2023. DOI: 10.47750/jptcp.2023.30.05.061. Disponível em: https://jptcp.com/index.php/jptcp/article/view/1708. Acesso em: 16 jul. 2024.